Announcement on the Holding Subsidiary Obtaining the Supplementary Application Approval Notice for Sildenafil Citrate Tablets and Becoming the Marketing Authorization Holder of the Drug

About this update from Shandong Lukang Pharmaceutical Co., Ltd. Class A

Announcement on the Holding Subsidiary Obtaining the Supplementary Application Approval Notice for Sildenafil Citrate Tablets and Becoming the Marketing Authorization Holder of the Drug The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shandong Lukang Pharmaceutical Co., Ltd. Class A